Events

Get your 2020 networking started! We hope to see existing and future MVA members, decision makers and everybody else with an interest in the future of Medicon Valley, for a glass of Cava and some tapas to welcome a hopefully

Cancer is a terrible disease that hits one in three Danish citizens. We have come a long way with cancer plans and cancer packages. However, there is still a strong need for political action, especially when it comes to prevention,

Medicon Valley Alliance are partnering with LSX to deliver the LSX World Congress 2020. For 5 years, the LSX World Congress has been bringing together the executives that matter to the future of healthcare and life science strategy, investment, partnering

Do you have a strategy for building analytic excellence in your organization?   Your competitors do. Organizations that take an enterprise approach to analytics outperform their competition. By making analytics the cornerstone of problem solving and decision making in every facet of

The Hanseatic League of Science (HALOS), www.halos-science.uk invites you to participate in the HALOS Annual meeting on the 6th of February 2020 in Hamburg.  Join us and take the chance to learn more about how your organization can benefit from the large facilities in the

INVITATION FOR THE 2nd LIFE-ON-CHIP CONFERENCE – Enabling personalized medicine by cross-over innovation  Do you want to know more about the latest cross-over innovations? Then you certainly have to attend our 2nd ‘Life-on-Chip Conference – Enabling personalized medicine through cross-over

Medicon Valley Alliance would like to draw your attention to the upcoming Patient Partnering in Clinical Development conference in Berlin on 2-3 March 2020. Date: 2 and 3 March 2020 Venue: Courtyard Berlin City Center, Berlin MVA members can register

International Symposium for PhD students in Life Sciences The VIBes in Bioscience PhD conference is an initiative from the Flanders Institute for Biotechnology (VIB) that takes place in Belgium. The organizing committee consists of motivated VIB PhD students, who bring

An Innovative Medicines Initiative Project for Precision Therapy and Prevention of Diabetes RHAPSODY (“Risk Assessment and ProgreSsiOn of DIabetes”), a public private consortium funded by the Innovative Medicines Initiative (IMI) and EFPIA Companies with contributions from academic institutions, has announced